KIMS shares surge over 4% after company enters agreement for 100% acquisition

Krishna Institute of Medical Sciences saw a 4.4% increase in shares following the acquisition of Chalasani Hospitals.

Shares of surged 4.4% on after the company announced that it has entered into a definitive agreement for acquiring a 100% stake in Chalasani Hospitals.

“Pursuant to the approval of the Board, we are pleased to inform that the Company has entered into a definitive agreement for of a 200-bed multi-specialty hospital at a prime location in ,” informed the company via a filing to the stock exchanges.

KIMS already has a multi-speciality hospital and gastro unit at Vizag and this addition is likely to help the company garner a larger share in the market. Besides, the hospital is situated in a prime locality which makes it an attractive proposition.

“This is our 2nd Hospital in Visakhapatnam (KIMS-ICON Hospitals was acquired in 2018). It underscores the tremendous opportunity we see in this city and we’ll continue to look for inorganic opportunities to build on our dominant position in Andhra Pradesh. With the addition of Queen's NRI Hospital, we now have over 630 beds in Vishakapatnam to provide world class healthcare facilities,” said B. Bhaskara Rao, CMD, KIMS Hospitals.

Also read:

The company’s filing states that Queen's NRI Hospital is a 200-bed hospital at a prime location in Vizag. It was established in 1995 with a built-up area of around 1,50,000 sq ft.

In the last one year, the shares of KIMS have given returns of 20% while in the last 3 months alone, the stock has surged 7%, as per the Trendlyne data.

According to the same data, the stock has increased by 2.5% and 12.8% in the last 1 week and 1 month respectively.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source: Stocks-Markets-Economic Times

Publicații recente
Car parts supplier Forvia cuts 2024 outlook again, to speed up job cuts
27.09.2024 - 16:00
Costco dips premarket; Bristol-Myers Squibb, Wynn Resorts rise
27.09.2024 - 16:00
Forvia rises on better-than-feared guidance cut
27.09.2024 - 16:00
Commerzbank's designated CEO meets UniCredit in first talks, sources say
27.09.2024 - 16:00
Ceres surges after 'solid numbers update'
27.09.2024 - 16:00
Strike looms at US East Coast, Gulf of Mexico ports
27.09.2024 - 16:00
Bristol-Myers Squibb stock gains on FDA approval of schizophrenia treatment
27.09.2024 - 16:00
Exclusive-German finance minister tells Italy of his concerns on UniCredit move, sources say
27.09.2024 - 16:00
Deutsche Bank restarts Dell coverage at Buy on bullish growth outlook
27.09.2024 - 16:00
AI to redefine traffic funnels, conversions for online marketplaces: Raymond James
27.09.2024 - 16:00
KeyBanc downgrades dating app Bumble to "Sector Weight"
27.09.2024 - 16:00
Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement
27.09.2024 - 16:00
Zara owner Inditex adds to gains as BofA calls it 'best-in-class fashion retailer'
27.09.2024 - 15:00
Analysts turn bearish on Ubisoft as shares slump
27.09.2024 - 15:00
S&P, Dow futures hover near flatline ahead of fresh US economic data
27.09.2024 - 15:00

© Analytic DC. All Rights Reserved.

new
Analiza pieței Strategia intraday CAC 40
Bine ați venit în mesageria de suport!!
*
*

Solicitarea dvs. a fost trimisă cu succes!
Veți fi contactat în scurt timp.